HEADER TRANSFERASE 13-MAY-05 1ZOH TITLE CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- TITLE 2 DERIVATIVES INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE CK2, ALPHA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II, CK2-ALPHA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ZEA MAYS; SOURCE 3 ORGANISM_TAXID: 4577; SOURCE 4 GENE: ACK2; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE CK2, TETRABROMO-BENZIMIDAZOLE, TBB, INHIBITORS, KEYWDS 2 PHARMACOPHORE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.BATTISTUTTA,M.MAZZORANA,S.SARNO,Z.KAZIMIERCZUK,G.ZANOTTI,L.A.PINNA REVDAT 3 14-FEB-24 1ZOH 1 REMARK REVDAT 2 24-FEB-09 1ZOH 1 VERSN REVDAT 1 29-NOV-05 1ZOH 0 JRNL AUTH R.BATTISTUTTA,M.MAZZORANA,S.SARNO,Z.KAZIMIERCZUK,G.ZANOTTI, JRNL AUTH 2 L.A.PINNA JRNL TITL INSPECTING THE STRUCTURE-ACTIVITY RELATIONSHIP OF PROTEIN JRNL TITL 2 KINASE CK2 INHIBITORS DERIVED FROM TETRABROMO-BENZIMIDAZOLE. JRNL REF CHEM.BIOL. V. 12 1211 2005 JRNL REFN ISSN 1074-5521 JRNL PMID 16298300 JRNL DOI 10.1016/J.CHEMBIOL.2005.08.015 REMARK 2 REMARK 2 RESOLUTION. 1.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.0 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.165 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.165 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1584 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.153 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.153 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1296 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 24543 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2718 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 379 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3120.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 1 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 12508 REMARK 3 NUMBER OF RESTRAINTS : 11303 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 ANGLE DISTANCES (A) : 0.022 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.024 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.034 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.041 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.009 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.074 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE REMARK 3 METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST.28(1995)53-56 REMARK 4 REMARK 4 1ZOH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-05. REMARK 100 THE DEPOSITION ID IS D_1000032957. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.2 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31911 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 15.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, SODIUM ACETATE, TRIS, PH REMARK 280 8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 71.78000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.54500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 71.78000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.54500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1156 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1171 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1255 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1273 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 332 REMARK 465 SER A 333 REMARK 465 ARG A 334 REMARK 465 THR A 335 REMARK 465 ARG A 336 REMARK 465 ALA A 337 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 6 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 80 CD - NE - CZ ANGL. DEV. = 9.1 DEGREES REMARK 500 TYR A 257 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 TYR A 261 CB - CG - CD1 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG A 312 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 156 44.41 -152.70 REMARK 500 ASP A 175 78.21 51.90 REMARK 500 ALA A 193 -179.49 57.94 REMARK 500 ASP A 205 30.21 72.05 REMARK 500 ASP A 208 58.57 -95.62 REMARK 500 ASP A 210 -157.23 -150.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K44 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZOE RELATED DB: PDB REMARK 900 RELATED ID: 1ZOG RELATED DB: PDB DBREF 1ZOH A 6 337 UNP P28523 CSK2A_MAIZE 1 332 SEQRES 1 A 332 MET SER LYS ALA ARG VAL TYR ALA ASP VAL ASN VAL LEU SEQRES 2 A 332 ARG PRO LYS GLU TYR TRP ASP TYR GLU ALA LEU THR VAL SEQRES 3 A 332 GLN TRP GLY GLU GLN ASP ASP TYR GLU VAL VAL ARG LYS SEQRES 4 A 332 VAL GLY ARG GLY LYS TYR SER GLU VAL PHE GLU GLY ILE SEQRES 5 A 332 ASN VAL ASN ASN ASN GLU LYS CYS ILE ILE LYS ILE LEU SEQRES 6 A 332 LYS PRO VAL LYS LYS LYS LYS ILE LYS ARG GLU ILE LYS SEQRES 7 A 332 ILE LEU GLN ASN LEU CYS GLY GLY PRO ASN ILE VAL LYS SEQRES 8 A 332 LEU LEU ASP ILE VAL ARG ASP GLN HIS SER LYS THR PRO SEQRES 9 A 332 SER LEU ILE PHE GLU TYR VAL ASN ASN THR ASP PHE LYS SEQRES 10 A 332 VAL LEU TYR PRO THR LEU THR ASP TYR ASP ILE ARG TYR SEQRES 11 A 332 TYR ILE TYR GLU LEU LEU LYS ALA LEU ASP TYR CYS HIS SEQRES 12 A 332 SER GLN GLY ILE MET HIS ARG ASP VAL LYS PRO HIS ASN SEQRES 13 A 332 VAL MET ILE ASP HIS GLU LEU ARG LYS LEU ARG LEU ILE SEQRES 14 A 332 ASP TRP GLY LEU ALA GLU PHE TYR HIS PRO GLY LYS GLU SEQRES 15 A 332 TYR ASN VAL ARG VAL ALA SER ARG TYR PHE LYS GLY PRO SEQRES 16 A 332 GLU LEU LEU VAL ASP LEU GLN ASP TYR ASP TYR SER LEU SEQRES 17 A 332 ASP MET TRP SER LEU GLY CYS MET PHE ALA GLY MET ILE SEQRES 18 A 332 PHE ARG LYS GLU PRO PHE PHE TYR GLY HIS ASP ASN HIS SEQRES 19 A 332 ASP GLN LEU VAL LYS ILE ALA LYS VAL LEU GLY THR ASP SEQRES 20 A 332 GLY LEU ASN VAL TYR LEU ASN LYS TYR ARG ILE GLU LEU SEQRES 21 A 332 ASP PRO GLN LEU GLU ALA LEU VAL GLY ARG HIS SER ARG SEQRES 22 A 332 LYS PRO TRP LEU LYS PHE MET ASN ALA ASP ASN GLN HIS SEQRES 23 A 332 LEU VAL SER PRO GLU ALA ILE ASP PHE LEU ASP LYS LEU SEQRES 24 A 332 LEU ARG TYR ASP HIS GLN GLU ARG LEU THR ALA LEU GLU SEQRES 25 A 332 ALA MET THR HIS PRO TYR PHE GLN GLN VAL ARG ALA ALA SEQRES 26 A 332 GLU ASN SER ARG THR ARG ALA HET NA A 601 1 HET CL A 701 1 HET CL A 702 1 HET K44 A 501 17 HET EDO A 801 4 HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM K44 5,6,7,8-TETRABROMO-1-METHYL-2,3-DIHYDRO-1H-IMIDAZO[1,2- HETNAM 2 K44 A]BENZIMIDAZOLE HETNAM EDO 1,2-ETHANEDIOL HETSYN K44 N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO- HETSYN 2 K44 BENZIMIDAZOLE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 NA NA 1+ FORMUL 3 CL 2(CL 1-) FORMUL 5 K44 C10 H7 BR4 N3 FORMUL 6 EDO C2 H6 O2 FORMUL 7 HOH *379(H2 O) HELIX 1 1 ASP A 14 ARG A 19 1 6 HELIX 2 2 PRO A 20 ASP A 25 1 6 HELIX 3 3 TYR A 26 LEU A 29 5 4 HELIX 4 4 GLU A 35 ASP A 37 5 3 HELIX 5 5 LYS A 74 CYS A 89 1 16 HELIX 6 6 ASP A 120 TYR A 125 1 6 HELIX 7 7 PRO A 126 LEU A 128 5 3 HELIX 8 8 THR A 129 GLN A 150 1 22 HELIX 9 9 LYS A 158 HIS A 160 5 3 HELIX 10 10 SER A 194 LYS A 198 5 5 HELIX 11 11 GLY A 199 VAL A 204 1 6 HELIX 12 12 TYR A 211 ARG A 228 1 18 HELIX 13 13 ASP A 237 GLY A 250 1 14 HELIX 14 14 GLY A 250 TYR A 261 1 12 HELIX 15 15 ASP A 266 GLY A 274 1 9 HELIX 16 16 PRO A 280 MET A 285 5 6 HELIX 17 17 SER A 294 LYS A 303 1 10 HELIX 18 18 ASP A 308 ARG A 312 5 5 HELIX 19 19 THR A 314 THR A 320 1 7 HELIX 20 20 HIS A 321 TYR A 323 5 3 HELIX 21 21 PHE A 324 GLU A 331 1 8 SHEET 1 A 5 TYR A 39 ARG A 47 0 SHEET 2 A 5 SER A 51 ASN A 58 -1 O GLU A 55 N ARG A 43 SHEET 3 A 5 GLU A 63 LEU A 70 -1 O CYS A 65 N GLY A 56 SHEET 4 A 5 PRO A 109 GLU A 114 -1 O PHE A 113 N ILE A 66 SHEET 5 A 5 LEU A 97 ARG A 102 -1 N LEU A 98 O ILE A 112 SHEET 1 B 2 ILE A 152 MET A 153 0 SHEET 2 B 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 C 2 VAL A 162 ASP A 165 0 SHEET 2 C 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 LINK OD1 ASP A 175 NA NA A 601 1555 1555 2.80 CISPEP 1 GLU A 230 PRO A 231 0 -1.27 SITE 1 AC1 4 PHE A 113 ASP A 175 K44 A 501 HOH A1043 SITE 1 AC2 2 ARG A 134 HOH A1155 SITE 1 AC3 4 GLY A 48 LYS A 49 TYR A 50 SER A 51 SITE 1 AC4 10 ILE A 66 LYS A 68 PHE A 113 GLU A 114 SITE 2 AC4 10 VAL A 116 MET A 163 ILE A 174 ASP A 175 SITE 3 AC4 10 NA A 601 HOH A1157 SITE 1 AC5 7 VAL A 95 LYS A 96 GLU A 114 VAL A 116 SITE 2 AC5 7 ARG A 172 HOH A1207 HOH A1407 CRYST1 143.560 61.090 44.690 90.00 102.70 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006966 0.000000 0.001570 0.00000 SCALE2 0.000000 0.016369 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022938 0.00000